05/08/2024
6:54 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
6:49 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B3 | |
04/10/2024
6:46 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
04/05/2024
6:39 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-3/A | |
04/01/2024
4:27 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/26/2024
7:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
6:34 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
7:24 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
8:39 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/02/2024
8:22 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:13 PM | Guenther Sven (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:14 PM | Mickle Christal M M (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:17 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:08 PM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:10 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:11 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:13 AM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SC 13G | |
01/23/2024
6:37 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:03 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
6:40 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B5 | |
11/20/2023
6:36 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:25 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
3:42 PM | ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 425 | |
10/30/2023
7:25 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:33 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
10/10/2023
7:20 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
4:07 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B3 | |
10/10/2023
4:12 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:06 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-4/A | |
09/28/2023
8:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2023
3:39 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:40 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
4:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
4:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
08/31/2023
7:01 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The ONE AI Stock to own now. (It’s not Nvidia.) (Ad) Don’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. |
08/31/2023
7:03 AM | ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 425 | |
08/25/2023
3:19 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:07 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
3:34 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:14 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:19 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:35 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
10:34 AM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
4:53 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
6:57 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/11/2023
7:02 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
